Post by Deep Piction

Last week, our CEO & Co-founder Ali Maximilian Ertürk shared at #BayOConnect2026 how Deep Piction's In Vivo precision therapeutics engine combines whole-body imaging, AI, and cell-level analysis to generate the evidence needed for the next generation of targeted therapies. From inspiring discussions with researchers and biotech innovators to conversations with potential collaborators and partners, BayOConnect 2026 highlighted the growing momentum behind technologies accelerating therapeutic discovery and translation. A big thank you to everyone who attended the session and shared ideas with our team. We're excited about the collaborations and conversations that began in Munich, and we're looking forward to what's next! #BayOConnect #Biotech #PrecisionMedicine #DrugDiscovery #AI #Imaging #LifeSciences #Innovation #DeepPiction